Extramedullary Manifestation in Multiple Myeloma Bears High Incidence of Poor Cytogenetic Aberration and Novel Agents Resistance

Table 2

Clinical and FISH data of MM patients with EMD at relapse stage.

		14
Age (median) range in years		58 (39–78)
Sex (male/female)		11/3
Stage (Durie-Salmon)	IIIA	11
	IIIB	3
Stage (ISS)	I	4
	II	5
	III	5
MM type	IgG	5
	IgA	6
	IgM	1
	Light chain	2
FISH result	del(17p13)	3
	del(13q14)	4
	amp(1q21)	4
	Not available	6
Involved sites	Soft tissues	8
	Central nervous system	4
	Skin	2
	Liver	2
Median time to EMR (month)		16.5 (3–70)